Radiotherapy in the adjuvant setting of cervical carcinoma: treatment, results, and prognostic factors

被引:5
|
作者
Atahan, I. L.
Yildiz, F. [1 ]
Ozyar, E.
Pehlivan, B.
Genc, M.
Kose, M. F.
Tulunay, G.
Ayhan, A.
Yuce, K.
Guler, N.
Kucukali, T.
机构
[1] Hacettepe Univ, Fac Med, Dept Radiat Oncol, TR-06100 Ankara, Turkey
[2] Selcuk Univ, Fac Med, Dept Radiat Oncol, Konya, Turkey
[3] SSK Ankara Matern & Womens Hlth Teaching Hosp, Dept Gynecol Oncol, Ankara, Turkey
[4] Hacettepe Univ, Fac Med, Dept Med Oncol, TR-06100 Ankara, Turkey
[5] Hacettepe Univ, Fac Med, Dept Pathol, TR-06100 Ankara, Turkey
[6] Hacettepe Univ, Fac Med, Dept Obstet & Gynecol, TR-06100 Ankara, Turkey
关键词
cervical cancer; prognostic factors; radiotherapy;
D O I
10.1111/j.1525-1438.2007.00887.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To evaluate the efficacy of postoperative radiotherapy and to investigate prognostic factors for early-stage cervical cancer patients. From December 1993 to December 2001, 141 patients with stage I-II cervical cancer without para-aortic lymph node (LN) metastases and treated by surgery and postoperative radiotherapy (RT) were included in this study. Indications for postoperative external RT were based on pathologic findings, including LN metastasis, positive surgical margins, parametrial involvement, pT2 tumor, and presence of any two minor risk factors like lymphvascular space involvement, deep stromal invasion, and tumor diameter between 2-4 cm. Sixty-six (47%) patients received RT alone, whereas 59 (42%) were treated with RT and concomitant chemotherapy (CT), and 16 received neoadjuvant CT. Patients with positive vaginal margins also received 27.5 Gy high-dose rate vaginal cuff brachytherapy in five fractions. Median follow-up time was 55 months. The actuarial 5-year overall (OS), disease-free (DFS), locoregional recurrence-free (LRFS), and distant metastases-free (DMFS) survival rates are 70%, 68%, 77%, and 88%, respectively. Univariate and multivariate analyses revealed that level and number of metastatic LNs and concomitant CT were unique significant prognostic factors for OS, DFS, and LRFS. Endometrial involvement, on the other hand, was proven to be significant for DFS and DMFS. Patients with less than three LN metastases or having only obturator LN involvement showed similar prognosis with their counterparts having no LN metastases. On the other hand, patients with either common iliac LN or more than three LN metastases had significantly worse outcome. Our results indicate that level and number of metastatic LNs are the most important prognostic factors determining the survival rates, and patients with upper lymphatic involvement or more than three metastatic LNs seem to need more effective treatment approaches.
引用
收藏
页码:813 / 820
页数:8
相关论文
共 50 条
  • [11] Adjuvant radiotherapy in the management of male breast carcinoma: Survival and prognostic factors
    Zabel, A
    Milker-Zabel, S
    Zuna, I
    Wannenmacher, MF
    Debus, J
    RADIOLOGY, 2002, 225 : 168 - 168
  • [12] Adjuvant radiotherapy after radical hysterectomy of the cervical cancer - Prognostic factors and complications
    Chatani, M
    Nose, T
    Masaki, N
    Inoue, T
    STRAHLENTHERAPIE UND ONKOLOGIE, 1998, 174 (10) : 504 - 509
  • [13] Postoperative radiotherapy in early stage carcinoma of the uterine cervix: Treatment results and prognostic factors
    Yeh, SA
    Leung, SW
    Wang, CJ
    Chen, HC
    GYNECOLOGIC ONCOLOGY, 1999, 72 (01) : 10 - 15
  • [14] Treatment results and prognostic factors for radiotherapy of pituitary adenomas
    Krupska, T
    Zajusz, A
    Slosarek, K
    Maciejewska, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 276 - 276
  • [15] Lymphvascular invasion in stage IB cervical carcinoma: Prognostic significance and role of adjuvant radiotherapy
    Francke, P
    Maruyama, Y
    VanNagell, J
    DePriest, P
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1996, 6 (03) : 208 - 212
  • [16] Adjuvant radiotherapy of the cervical carcinoma in elderly patients
    Karapandzic, V. Plesinac
    Zoranovic, S.
    Tomasevic, A.
    Rakovic, B.
    Saric, M.
    Radonjic, M.
    Cihoric, N.
    EJC SUPPLEMENTS, 2007, 5 (04): : 177 - 177
  • [17] Colorectal cancer in the adjuvant setting: perspectives on treatment and the role of prognostic factors
    Cascinu, S
    Georgoulias, V
    Kerr, D
    Maughna, T
    Labianca, R
    Ychou, M
    ANNALS OF ONCOLOGY, 2003, 14 : 25 - 29
  • [18] The results of adjuvant radiotherapy in endometrial carcinoma
    Korcum, Aylin Fidan
    Duman, Evrim
    Aksu, Gamze
    GYNECOLOGICAL ENDOCRINOLOGY, 2010, 26 (04) : 240 - 245
  • [19] Adjuvant radiotherapy in stage 1 seminoma: Evaluation of prognostic factors and results of survival
    Serdar, Lasif
    Canyilmaz, Emine
    Topcu, Turkan Ozturk
    Sahbaz, Asli
    Memis, Yahyahan
    Soydemir, Gulsen
    Aynaci, Ozlem
    Kandaz, Mustafa
    Bahat, Zumrut
    Yoney, Adnan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (02) : 313 - 318
  • [20] Prognostic relevance of histomorphologic factors and adjuvant treatment in pancreatic carcinoma
    Wilkowski, R
    Assmann, G
    Nolte, A
    Diebold, J
    Löhrs, U
    Dühmke, E
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 16 - 16